You are here: Industry Insights > COVID-19 vaccine

News List

CanSino Biologics to start clinical trials of inhaled Covid-19 vaccine pharmaceutical-technology
April 21, 2021
Chinese company CanSino Biologics is set to commence clinical trials of a Covid-19 vaccine that can be administered through inhalation.
India approves $610 million grant for Serum Institute, Bharat Biotech to boost vaccine production capacity expresspharma
April 21, 2021
India’s government has approved a 45.67-billion-rupee ($610 million) grant for COVID-19 vaccine makers Serum Institute of India (SII) and Bharat Biotech to boost production capacity as infections spread at record speed, its finance minister said.
New COVID-19 vaccine may offer broad protection from coronaviruses worldpharmanews
April 20, 2021
A COVID-19 vaccine that could provide protection against existing and future strains of the COVID-19 coronavirus, and other coronaviruses, and cost about $1 a dose has shown promising results in early animal testing.
Sinovac’s Covid-19 vaccine prevents 67% symptomatic infections in study pharmaceutical-technology
April 20, 2021
The Chilean Ministry of Health has reported that the Chinese pharmaceutical company Sinovac Covid-19 vaccine CoronaVac demonstrated to be up to 67% effective in preventing symptomatic infections in a study.
Russia’s Sputnik V Covid-19 vaccine shows 97.6% efficacy pharmaceutical-technology
April 20, 2021
The Gamaleya National Research Center of Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF) have reported that the Sputnik V Covid-19 vaccine showed a 97.6% efficacy.
Pfizer, BioNTech Expand COVID-19 Vaccine Agreement with EU contractpharma
April 20, 2021
EU orders 100 million additional doses of COMIRNATY, bringing total doses to 600 million for 27 EU member states.
Inovio’s Covid-19 vaccine induces immune responses against variants pharmaceutical-technology
April 19, 2021
Inovio has reported that results from a study of its DNA Covid-19 vaccine candidate INO-4800 showed it induced a robust T cell response in humans against all spike protein variants of concern.
Haffkine Bio-Pharma to target 22.8 crore Covaxin vials annually expresspharma
April 19, 2021
After receiving permission to make Bharat Biotech’s COVID-19 vaccine Covaxin, Haffkine Bio-Pharmaceutical said it would take least at one year’s time for the company to start actual production.
PSUs roped in to ramp up COVID-19 vaccine production expresspharma
April 19, 2021
The production of indigenously developed COVID-19 vaccine Covaxin will be ramped up significantly and increased to 10 crore doses per month by September, the Department of Biotechnology said.
Oxford University expands Com-COV2 dose-mixing study with Novavax’s Covid-19 vaccine pharmaceutical-technology
April 16, 2021
The University of Oxford has expanded the Comparing Covid-19 Vaccine Schedule Combinations – Stage 2 (Com-COV2) study to include the Novavax and Moderna vaccines for the disease treatment.

Previous page 1 2 3 4 5 6 7 8 9 10 ... 116 117 Next page